C169H169N29O13 — CID 160674326
N-(1-adamantyl)-2-[4-(pyridine-2-carbonylamino)phenyl]-3H-benzimidazole-5-carboxamide;2-[4-(cycloheptanecarbonylamino)phenyl]-N-(2-phenylmethoxycyclopentyl)-3H-benzimidazole-5-carboxamide;N-cycloheptyl-2-[4-(pyridine-3-carbonylamino)phenyl]-3H-benzimidazole-5-carboxamide;N-cyclohexyl-2-[4-(pyridine-2-carbonylamino)phenyl]-3H-benzimidazole-5-carboxamide;N-cyclohexyl-2-[4-(pyridine-3-carbonylamino)phenyl]-3H-benzimidazole-5-carboxamide;N-cyclohexyl-2-[4-(pyridine-4-carbonylamino)phenyl]-3H-benzimidazole-5-carboxamide (PubChem CID 160674326) has the molecular formula C169H169N29O13 and a molecular weight of 2814.40 g/mol. Its IUPAC name is N-(1-adamantyl)-2-[4-(pyridine-2-carbonylamino)phenyl]-3H-benzimidazole-5-carboxamide;2-[4-(cycloheptanecarbonylamino)phenyl]-N-(2-phenylmethoxycyclopentyl)-3H-benzimidazole-5-carboxamide;N-cycloheptyl-2-[4-(pyridine-3-carbonylamino)phenyl]-3H-benzimidazole-5-carboxamide;N-cyclohexyl-2-[4-(pyridine-2-carbonylamino)phenyl]-3H-benzimidazole-5-carboxamide;N-cyclohexyl-2-[4-(pyridine-3-carbonylamino)phenyl]-3H-benzimidazole-5-carboxamide;N-cyclohexyl-2-[4-(pyridine-4-carbonylamino)phenyl]-3H-benzimidazole-5-carboxamide.
| Compound Name | N-(1-adamantyl)-2-[4-(pyridine-2-carbonylamino)phenyl]-3H-benzimidazole-5-carboxamide;2-[4-(cycloheptanecarbonylamino)phenyl]-N-(2-phenylmethoxycyclopentyl)-3H-benzimidazole-5-carboxamide;N-cycloheptyl-2-[4-(pyridine-3-carbonylamino)phenyl]-3H-benzimidazole-5-carboxamide;N-cyclohexyl-2-[4-(pyridine-2-carbonylamino)phenyl]-3H-benzimidazole-5-carboxamide;N-cyclohexyl-2-[4-(pyridine-3-carbonylamino)phenyl]-3H-benzimidazole-5-carboxamide;N-cyclohexyl-2-[4-(pyridine-4-carbonylamino)phenyl]-3H-benzimidazole-5-carboxamide |
|---|---|
| PubChem CID | 160674326 |
| Molecular Formula | C169H169N29O13 |
| Molecular Weight | 2814.40 g/mol |
| Exact Mass | 2812.35 |
| IUPAC Name | N-(1-adamantyl)-2-[4-(pyridine-2-carbonylamino)phenyl]-3H-benzimidazole-5-carboxamide;2-[4-(cycloheptanecarbonylamino)phenyl]-N-(2-phenylmethoxycyclopentyl)-3H-benzimidazole-5-carboxamide;N-cycloheptyl-2-[4-(pyridine-3-carbonylamino)phenyl]-3H-benzimidazole-5-carboxamide;N-cyclohexyl-2-[4-(pyridine-2-carbonylamino)phenyl]-3H-benzimidazole-5-carboxamide;N-cyclohexyl-2-[4-(pyridine-3-carbonylamino)phenyl]-3H-benzimidazole-5-carboxamide;N-cyclohexyl-2-[4-(pyridine-4-carbonylamino)phenyl]-3H-benzimidazole-5-carboxamide |
| SMILES | O=C(NC12CC3CC(CC(C3)C1)C2)c1ccc2nc(-c3ccc(NC(=O)c4ccccn4)cc3)[nH]c2c1.O=C(NC1CCCC1OCc1ccccc1)c1ccc2nc(-c3ccc(NC(=O)C4CCCCCC4)cc3)[nH]c2c1.O=C(NC1CCCCC1)c1ccc2nc(-c3ccc(NC(=O)c4ccccn4)cc3)[nH]c2c1.O=C(Nc1ccc(-c2nc3ccc(C(=O)NC4CCCCC4)cc3[nH]2)cc1)c1cccnc1.O=C(Nc1ccc(-c2nc3ccc(C(=O)NC4CCCCC4)cc3[nH]2)cc1)c1ccncc1.O=C(Nc1ccc(-c2nc3ccc(C(=O)NC4CCCCCC4)cc3[nH]2)cc1)c1cccnc1 |
| InChI | InChI=1S/C34H38N4O3.C30H29N5O2.C27H27N5O2.3C26H25N5O2/c39-33(25-11-6-1-2-7-12-25)35-27-18-15-24(16-19-27)32-36-28-20-17-26(21-30(28)37-32)34(40)38-29-13-8-14-31(29)41-22-23-9-4-3-5-10-23;36-28(35-30-15-18-11-19(16-30)13-20(12-18)17-30)22-6-9-24-26(14-22)34-27(33-24)21-4-7-23(8-5-21)32-29(37)25-3-1-2-10-31-25;33-26(29-21-7-3-1-2-4-8-21)19-11-14-23-24(16-19)32-25(31-23)18-9-12-22(13-10-18)30-27(34)20-6-5-15-28-17-20;32-25(28-20-6-2-1-3-7-20)18-10-13-22-23(15-18)31-24(30-22)17-8-11-21(12-9-17)29-26(33)19-5-4-14-27-16-19;32-25(28-19-6-2-1-3-7-19)18-11-14-21-23(16-18)31-24(30-21)17-9-12-20(13-10-17)29-26(33)22-8-4-5-15-27-22;32-25(18-12-14-27-15-13-18)29-21-9-6-17(7-10-21)24-30-22-11-8-19(16-23(22)31-24)26(33)28-20-4-2-1-3-5-20/h3-5,9-10,15-21,25,29,31H,1-2,6-8,11-14,22H2,(H,35,39)(H,36,37)(H,38,40);1-10,14,18-20H,11-13,15-17H2,(H,32,37)(H,33,34)(H,35,36);5-6,9-17,21H,1-4,7-8H2,(H,29,33)(H,30,34)(H,31,32);4-5,8-16,20H,1-3,6-7H2,(H,28,32)(H,29,33)(H,30,31);4-5,8-16,19H,1-3,6-7H2,(H,28,32)(H,29,33)(H,30,31);6-16,20H,1-5H2,(H,28,33)(H,29,32)(H,30,31) |
| InChIKey | RNILHWKBFCITCI-UHFFFAOYSA-N |
| XLogP | 32.73 |
| TPSA | 594.96 Ų |
| H-Bond Donors | 18 |
| H-Bond Acceptors | 24 |
| Rotatable Bonds | 33 |
| Heavy Atoms | 211 |
| Complexity | — |
4 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 2814.40 |
| LogP ≤ 5 | 32.73 |
| H-Bond Donors ≤ 5 | 18 |
| H-Bond Acceptors ≤ 10 | 24 |